TSXV:NRX Nurexone Biologic leading biotech plays in 2024 with several recent developments from newly uplisting on the OTC, leasing agreement until 2028 of a state-of-the-art facility on a University campus in Israel to beginning clinical trials shortly.
Showcasing the recent developments of TSXV:NRX , will be upgrading on the OTC very soon which should help the volume. Currently holding the 200MA.
Element's volume has increased 260% from a previous 50+ days, also it's upward trend has increased 40%. With gold again reaching a new all-time-high last week and Element ramping up to begin reproduction at it's Lucero project it's well worth considering this junior.
Quite the panic as of late, fear rising in the markets. Take a second to zoom out. Let's see if it holds 370$.
The descending triangle (bearish signal) has played itself out confirming it's break below support and and is now forming a descending wedge (bullish signal). This pattern is confirmed with 3 reaction highs and 2 reaction lows (lower highs, lower lows). The daily chart looks primed for a breakout, the hour chart looks exhausted and may need a pull back. Will be...
Initially investors believed a cup and handle formation was forming on QYOU. Amazon news was dropped at an opportune time on the handle but seemed to fall on deaf ears and began forming a descending triangle.
QYOU's last consolidation phase started around February 2nd and lasted until February 5th. (3days)